332 Participants Needed

Educational Video + Fact Sheet for Breast and Ovarian Cancer Risk Awareness

Recruiting at 1 trial location
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Georgetown University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial is testing a special video in Spanish against a simple information sheet to help Latina women at risk for breast and ovarian cancer understand genetic counseling and testing. The video is designed to connect emotionally and culturally with the women, making them more likely to take action. The study will see which method works better and how it can be used in community clinics.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on educational materials and genetic counseling, so it's unlikely that medication changes are required.

Is the educational video and fact sheet for breast and ovarian cancer risk awareness safe for humans?

The educational video and fact sheet have been used in studies with Latina women at risk for hereditary breast and ovarian cancer, and no safety concerns have been reported. The video was well-received and improved knowledge and attitudes without any noted adverse effects.12345

How does the treatment 'Culturally Targeted Narrative Video: 'Is My Cancer Hereditary? Rosa Visits a Genetic Counselor.' differ from other treatments for breast and ovarian cancer risk awareness?

This treatment is unique because it uses a culturally targeted narrative video specifically designed to improve genetic counseling uptake among Latina women at risk for hereditary breast and ovarian cancer. It addresses disparities in awareness and access by using simple language and visual aids, making it accessible to underserved populations with low literacy and English proficiency.12346

What data supports the effectiveness of the treatment Culturally Targeted Narrative Video: 'Is My Cancer Hereditary? Rosa Visits a Genetic Counselor.' for increasing awareness of breast and ovarian cancer risk?

Research shows that a culturally targeted video significantly improved knowledge, positive attitudes, and intentions to participate in genetic counseling among Latina women at risk for hereditary breast and ovarian cancer. This suggests that the video can effectively raise awareness and encourage participation in genetic counseling services.12357

Who Is on the Research Team?

AH

Alejandra Hurtado de Mendoza, Ph.D

Principal Investigator

Georgetown Lombardi Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This trial is for Latina women who are at least 18 years old, fluent in Spanish, and have not been involved in previous HBOC or GCT studies. They should meet the NCCN criteria for genetic cancer risk assessment due to personal or family history but haven't undergone genetic counseling or testing for hereditary breast and ovarian cancer.

Inclusion Criteria

No other family members are participating in this study
I identify as a Latina woman.
I work or volunteer at the partner community clinic.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants are randomized to either watch a culturally targeted narrative video or read a fact sheet about HBOC and genetic services

2 weeks
1 visit (in-person or virtual)

Follow-up

Participants are monitored for changes in subjective norms, beliefs, attitudes, and uptake of genetic counseling and testing

4 months

Implementation Evaluation

Community clinic staff participate in focus groups to assess the implementation outcomes of integrating HBOC screening practices

48 months

What Are the Treatments Tested in This Trial?

Interventions

  • Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor."
  • FORCE Fact Sheet
Trial Overview The study compares a culturally targeted video about hereditary breast and ovarian cancer (HBOC) with a Spanish-language fact sheet to see which is more effective at encouraging Latinas to get genetic counseling and testing. It also evaluates how well these tools can be implemented in community clinics.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Video ArmExperimental Treatment1 Intervention
Group II: Fact Sheet ArmActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Georgetown University

Lead Sponsor

Trials
355
Recruited
142,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Virginia Commonwealth University

Collaborator

Trials
732
Recruited
22,900,000+

Citations

Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. [2022]
Culturally Targeted Video Improves Psychosocial Outcomes in Latina Women at Risk of Hereditary Breast and Ovarian Cancer. [2023]
Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer. [2021]
Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer. [2023]
Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer. [2023]
Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings. [2021]
Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security